PDL BioPharma to Announce Third Quarter 2019 Financial Results on November 6, 2019
Conference Call Details
To access the live conference call via phone, please dial (844) 535-4071 from
To access the live and subsequently archived webcast of the conference call, go to the Company's website and go to "Events & Presentations." Please connect to the website at least 15 minutes prior to the call to allow for any software download that may be necessary.
PDL's mission is to improve the lives of patients and create value for our shareholders and our people by applying our capital and expertise for the successful development and commercialization of innovative therapeutics by our partner companies. We deliver on our mission by entering into strategic transactions involving innovative late clinical-stage or early commercial-stage therapeutics with attractive revenue growth potential. For more information please visit www.pdl.com.
View original content to download multimedia:http://www.prnewswire.com/news-releases/pdl-biopharma-to-announce-third-quarter-2019-financial-results-on-november-6-2019-300945219.html
LHA Investor Relations, Jody Cain, SVP, (310) 691-7100, firstname.lastname@example.org